26 related articles for article (PubMed ID: 6263318)
1. KH-17, a simplified derivative of bongkrekic acid, weakly inhibits the mitochondrial ADP/ATP carrier from both sides of the inner mitochondrial membrane.
Takegawa K; Ito T; Yamamoto A; Yamazaki N; Shindo M; Shinohara Y
Chem Biol Drug Des; 2023 Apr; 101(4):865-872. PubMed ID: 36527173
[TBL] [Abstract][Full Text] [Related]
2. High membrane potential promotes alkenal-induced mitochondrial uncoupling and influences adenine nucleotide translocase conformation.
Azzu V; Parker N; Brand MD
Biochem J; 2008 Jul; 413(2):323-32. PubMed ID: 18426390
[TBL] [Abstract][Full Text] [Related]
3. Four mutations in transmembrane domains of the mitochondrial ADP/ATP carrier increase resistance to bongkrekic acid.
Zeman I; Schwimmer C; Postis V; Brandolin G; David C; Trézéguet V; Lauquin GJ
J Bioenerg Biomembr; 2003 Jun; 35(3):243-56. PubMed ID: 13678275
[TBL] [Abstract][Full Text] [Related]
4. Chemical, immunological, enzymatic, and genetic approaches to studying the arrangement of the peptide chain of the ADP/ATP carrier in the mitochondrial membrane.
Brandolin G; Le Saux A; Trezeguet V; Lauquin GJ; Vignais PV
J Bioenerg Biomembr; 1993 Oct; 25(5):459-72. PubMed ID: 8132486
[TBL] [Abstract][Full Text] [Related]
5. Chemical modifications and active site labeling of the mitochondrial ADP/ATP carrier.
Block MR; Boulay F; Brandolin G; Lauquin GJ; Vignais PV
Methods Enzymol; 1986; 125():658-70. PubMed ID: 3012266
[No Abstract] [Full Text] [Related]
6. A fluorescent 3'-ADP-analog: interaction with oxidative phosphorylation and the adenine nucleotide carrier.
Schäfer G; Onur G
FEBS Lett; 1980 Jan; 109(2):197-201. PubMed ID: 6243581
[No Abstract] [Full Text] [Related]
7. Reconstitution of adenine nucleotide transport from beef heart mitochondria.
Krämer R; Klingenberg M
Biochemistry; 1979 Sep; 18(19):4209-15. PubMed ID: 486419
[No Abstract] [Full Text] [Related]
8. Atractyloside and bongkrekic acid sites in the mitochondrial ADP/ATP carrier protein. An appraisal of their unicity by chemical modifications.
Block MR; Lauguin GJ; Vignais PV
FEBS Lett; 1981 Aug; 131(2):213-8. PubMed ID: 6271570
[No Abstract] [Full Text] [Related]
9. Differential inactivation of atractyloside and bongkrekic acid binding sites on the adenine nucleotide carrier by ultraviolet light: its implication for the carrier mechanism.
Block MR; Lauquin GJ; Vignais PV
FEBS Lett; 1979 Aug; 104(2):425-30. PubMed ID: 478009
[No Abstract] [Full Text] [Related]
10. Chemical modifications of atractyloside and bongkrekic acid binding sites of the mitochondrial adenine nucleotide carrier. Are there distinct binding sites?
Block MR; Lauquin GJ; Vignais PV
Biochemistry; 1981 Apr; 20(9):2692-9. PubMed ID: 6263318
[No Abstract] [Full Text] [Related]
11. Inhibitors of the adenine nucleotide translocase.
Stubbs M
Pharmacol Ther; 1979; 7(2):329-50. PubMed ID: 392557
[No Abstract] [Full Text] [Related]
12. Molecular and physiological aspects of adenine nucleotide transport in mitochondria.
Vignais PV
Biochim Biophys Acta; 1976 Apr; 456(1):1-38. PubMed ID: 131583
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
